Finance

Lists
GENX:CVE
Genix Pharmaceuticals Corp
CAD 0,015
0,00%
(0,00) 1D
4 Nov., 15:59:59 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for GENX...
Mkt. cap
920,92 k
Avg. vol.
14,75 k
Volume
0,00
52-wk high
CAD 0,02
52-wk low
CAD 0,02
EPS
-CAD 0,01
Beta
0,84
Shares outstanding
61,22 m
Mkt. cap
920,92 k
Avg. vol.
14,75 k
Volume
0,00
52-wk high
CAD 0,02
52-wk low
CAD 0,02
EPS
-CAD 0,01
Beta
0,84
Shares outstanding
61,22 m
News stories
From web sources and news partners
About Genix Pharmaceuticals Corp
CEO-
Employees-
Founded1993
HeadquartersVancouver, Brits-Columbië, Kanada
SectorConsumer Staples
IndustryPersonal care products
Websitegenixpharm.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jul. 2025
Okt. 2025
Jan. 2026
Apr. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,45 k
30,90 k
21,28 k
23,20 k
Operating expense
32,73 k
31,18 k
21,28 k
23,20 k
Total operating expenses
32,73 k
31,18 k
21,28 k
23,20 k
Operating income
-32,73 k
-31,18 k
-21,28 k
-23,20 k
Other non operating income
-7,96 k
-2,35 k
-2,42 k
-3,70 k
EBT including unusual items
-83,50 k
-92,32 k
-51,64 k
-78,42 k
EBT excluding unusual items
-83,50 k
-86,68 k
-51,64 k
-78,42 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-83,50 k
-92,32 k
-51,64 k
-78,42 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
25,00
129,00
164,00
66,00
Interest expense
-42,01 k
-48,53 k
-40,56 k
-49,89 k
Net interest expenses
-41,99 k
-48,40 k
-40,40 k
-49,82 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-32,45 k
-30,90 k
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme